Pimobendan 74150-27-9 Metabolismus PDE inhibitor
Mercedem:T/T, L/C
Product Origin:China
Shipping Portus:Beijing/Shanghai/Hangzhou
Order (MOQ);1g
Tempus ducere:III opus diebus
Facultas productio;1kg / mensis
Repono conditione:Condita in loco frigido, sicco, cella temperie.
Sarcina materia:phialam, lagenam
Sarcina amplitudo:1g/ phialam, 5/ phialam, 10g/ phialam, 50g/ utrem, 500g/ utrem
Salus notitia:UN 2811 6.1/PG 3

Introductio
Pimobendan, medicamentum VETERINARIUS.Calcium sensitivum est et inhibitor selectivorum phosphodiesteraseos 3 (PDE3) cum effectibus inotropicis et vasodilatoris positivis.
Pimobendan in administratione cordis defectionis in canibus adhibetur, maxime causata ex valvae myxomatous mitrali morbo (etiam antea endocardiosis), vel cardiomyopathy dilatato.Investigatio demonstravit pimobendan ut monotherapia superesset tempus augere et meliorem qualitatem vitae in aegros caninis cum corde congestivo defectum secundae ad morbum valvae mitralis comparatum cum benazepril, inhibitore ACE.
Specification (USP43)
Item | Specification |
Aspectus | Pulvis albidus vel subluteus, hygroscopic |
Mp | About 242℃ |
Solubilitas | In aqua fere solubilis, libere solubilis in dimethylformaide, leviter solubilis in acetoneo et in methanilia. |
Lepidium sativum | Effusio spectrophotometriae infrared, Comparatio pimobendan CRS. |
Retentionis tempus solutionis maioris cacuminis sample solutionis respondet solutioni stirpis Standardi, prout in Impuritatibus organicis habetur. | |
Metalla gravis | ≤10ppm |
Granularity | P90 ≤ 25μ m |
Magnitudo particula | 20-80 reticulum |
RELICTUM menstrua | ≤ 500ppm |
Aquae | ≤ 1.0% |
Assay | 98.0%~ 102.0% |
Cinis sulphated | ≤ 0.10% |
Substantiae cognatae (HPLC) | |
immunditiam A | ≤ 0.10% |
immunditiam B * | ≤ 0.10% |
Alia immunditia | ≤ 0.10% |
Totalis immunditiae | ≤ 0.20% |